IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,088,368 | -12.4% | 424,545 | -3.2% | 0.01% | -16.7% |
| Q2 2023 | $4,665,512 | +26.4% | 438,488 | +25.0% | 0.01% | +20.0% |
| Q1 2023 | $3,690,027 | +114.3% | 350,763 | +152.4% | 0.01% | +66.7% |
| Q4 2022 | $1,721,529 | -100.0% | 138,945 | -76.3% | 0.00% | -70.0% |
| Q3 2022 | $6,078,958,000 | +1259.2% | 586,772 | +1412.7% | 0.01% | +900.0% |
| Q2 2022 | $447,249,000 | +149.0% | 38,790 | +171.7% | 0.00% | – |
| Q1 2022 | $179,605,000 | -54.1% | 14,277 | -57.4% | 0.00% | -100.0% |
| Q4 2021 | $391,181,000 | -7.2% | 33,549 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $421,747,000 | +129.4% | 32,293 | +126.0% | 0.00% | – |
| Q2 2021 | $183,861,000 | -95.1% | 14,286 | -95.7% | 0.00% | -100.0% |
| Q1 2021 | $3,748,006,000 | +1451.7% | 335,242 | +1480.8% | 0.01% | – |
| Q4 2020 | $241,548,000 | -29.5% | 21,207 | -44.3% | 0.00% | – |
| Q3 2020 | $342,539,000 | +45.8% | 38,081 | +67.3% | 0.00% | – |
| Q2 2020 | $234,873,000 | -69.2% | 22,759 | -69.9% | 0.00% | -100.0% |
| Q1 2020 | $763,591,000 | +159.2% | 75,678 | +241.9% | 0.00% | +100.0% |
| Q4 2019 | $294,577,000 | +24.3% | 22,132 | -19.8% | 0.00% | – |
| Q3 2019 | $236,963,000 | +14.4% | 27,602 | +45.8% | 0.00% | – |
| Q2 2019 | $207,050,000 | -53.1% | 18,926 | -42.0% | 0.00% | -100.0% |
| Q1 2019 | $441,294,000 | +1200.6% | 32,616 | +895.9% | 0.00% | – |
| Q4 2018 | $33,929,000 | -76.7% | 3,275 | -58.5% | 0.00% | – |
| Q3 2018 | $145,668,000 | +5.2% | 7,891 | +8.9% | 0.00% | – |
| Q2 2018 | $138,524,000 | -69.0% | 7,245 | -75.0% | 0.00% | -100.0% |
| Q1 2018 | $446,359,000 | +7.4% | 28,928 | +4.3% | 0.00% | 0.0% |
| Q4 2017 | $415,658,000 | +63.2% | 27,729 | +71.7% | 0.00% | 0.0% |
| Q3 2017 | $254,670,000 | -20.9% | 16,149 | -5.3% | 0.00% | 0.0% |
| Q2 2017 | $321,828,000 | +624.2% | 17,046 | +554.4% | 0.00% | – |
| Q1 2017 | $44,441,000 | -32.6% | 2,605 | -39.6% | 0.00% | – |
| Q4 2016 | $65,976,000 | -61.4% | 4,315 | -59.9% | 0.00% | -100.0% |
| Q3 2016 | $170,980,000 | +160.3% | 10,767 | +114.2% | 0.00% | – |
| Q2 2016 | $65,690,000 | -78.0% | 5,026 | -80.5% | 0.00% | -100.0% |
| Q4 2015 | $298,604,000 | +10.1% | 25,764 | -1.1% | 0.00% | 0.0% |
| Q3 2015 | $271,326,000 | +114.7% | 26,039 | +148.5% | 0.00% | – |
| Q2 2015 | $126,353,000 | +178.0% | 10,477 | +268.8% | 0.00% | – |
| Q1 2015 | $45,456,000 | -50.1% | 2,841 | -59.6% | 0.00% | – |
| Q3 2014 | $91,096,000 | +2396.5% | 7,029 | +2853.4% | 0.00% | – |
| Q2 2014 | $3,649,000 | +298.8% | 238 | +186.7% | 0.00% | – |
| Q1 2014 | $915,000 | -93.5% | 83 | -93.1% | 0.00% | – |
| Q4 2013 | $14,013,000 | -95.4% | 1,207 | -95.3% | 0.00% | – |
| Q3 2013 | $305,555,000 | -7.4% | 25,807 | -22.2% | 0.00% | – |
| Q2 2013 | $329,902,000 | – | 33,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |